Conavi Medical to Participate in the MedInvest MedTech, AI & Digital Health Conference – Marks first time as a public company that Conavi is presenting at an investor event – – Live webcast presentation on Wednesday, December 11ᵗʰ at 3:35 p.m. ET – TORONTO, Dec. 10, 2024 (GLOBE...

JACC: Cardiovascular Interventions Publishes Peer-Reviewed Article on Emerging Hybrid Intracoronary Imaging Technologies – Conavi Medical’s Novasight Hybrid™ System is the first technology to combine both IVUS and OCT to enable simultaneous and co-registered imaging of coronary arteries – – Company showcasing its...

Conavi Medical Corp. Engages ICP Securities Inc. for Automated Market Making Services TORONTO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- CONAVI MEDICAL CORP. (TSXV: CNVI) (“CONAVI MEDICAL” or the “Company”), a commercial stage company focused on designing, manufacturing, and marketing...

Conavi Medical Corp. Commences Trading on TSX-V Under Symbol “CNVI” TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (formerly, “Titan Medical Inc.”) (“Conavi” or the “Company”) (TSXV: CNVI) is pleased to announce that, pursuant to its press releases...